Add Yahoo as a preferred source to see more of our stories on Google. The National Institute of Allergy and Infectious Diseases said a new treatment for bloodborne staph infections showed promise in a ...

Study shows efficacy and safety of oral antibiotic therapy in the form of pills for Staphylococcus aureus bloodstream infections. Currently, infusions are the standard treatment. An international ...

"Hearst Magazines and Yahoo may earn commission or revenue on some items through these links." There are plenty of infections that you get on a regular basis, such as a cold or a stomach bug, and ...

As mentioned earlier, there is an urgent need for the development of novel antibiotics targeting S. aureus. Fortunately, a number of new agents active against MRSA and other Gram-positive pathogens ...

MRSE and MRSA are bacterial infections caused by the Staphylococcus genus. These infections are resistant to several types of antibiotics, making them more difficult to treat. They can cause serious ...

An NIH-funded trial found that two IV doses of dalbavancin, given a week apart, were as safe and effective as 4–6 weeks of standard IV antibiotics for complicated Staphylococcus aureus bloodstream ...

Methicillin-resistant Staphylococcus epidermidis (MRSE) is a drug-resistant form of staph bacteria. MRSE infections may be difficult to treat due to their resistance to methicillin and other common ...

Topline data anticipated in Q1 2025 to support potential initiation of a pivotal bacteremia efficacy trial in 2025 LOS ANGELES, Nov. 12, 2024 /PRNewswire/ -- Armata Pharmaceuticals, Inc. (ARMP) ...

Lincoln, Neb. — Researchers at the University of Nebraska–Lincoln are working to halt resistance to an antibiotic used to treat serious staph infections in humans. Staphylococcus aureus is a bacterium ...

DEAR DR. ROACH: In December 2023, I had an open-heart aortic valve replacement. All went well, but then I contracted a staph infection. I had to have a second procedure to remove the top four sternal ...

LOS ANGELES, Nov. 12, 2024 /PRNewswire/ -- Armata Pharmaceuticals, Inc. (NYSE American: ARMP) ("Armata" or the "Company"), a clinical-stage biotechnology company focused on pathogen-specific ...